A detailed history of Pnc Financial Services Group, Inc. transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 9,894 shares of PLSE stock, worth $179,872. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,894
Previous 19,789 50.0%
Holding current value
$179,872
Previous $221,000 21.72%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$10.83 - $21.83 $107,162 - $216,007
-9,895 Reduced 50.0%
9,894 $173,000
Q4 2023

Feb 09, 2024

BUY
$3.85 - $12.84 $76,187 - $254,090
19,789 New
19,789 $242,000
Q1 2022

May 12, 2022

SELL
$4.21 - $14.79 $143 - $502
-34 Closed
0 $0
Q2 2020

Aug 07, 2020

BUY
$6.23 - $13.09 $211 - $445
34 New
34 $0
Q4 2019

Feb 07, 2020

SELL
$12.58 - $15.97 $3,774 - $4,791
-300 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$10.26 - $24.97 $3,078 - $7,491
300
300 $0

Others Institutions Holding PLSE

About Pulse Biosciences, Inc.


  • Ticker PLSE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 37,125,900
  • Market Cap $675M
  • Description
  • Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...
More about PLSE
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.